Cervical microbiota dysbiosis associated with high-risk Human Papillomavirus infection
暂无分享,去创建一个
M. Dąbrowska | M. Kulecka | A. Słabuszewska-Jóżwiak | Natalia Żeber-Lubecka | Katarzyna Bagińska-Drabiuk | Maria Głowienka-Stodolak | Andrzej Nowakowski | Bożena Bednorz | Ilona Jędrzejewska | Magdalena Piasecka | Jolanta Pawelec | Elzbieta Wojciechowska-Lampka | Jerzy Ostrowski
[1] M. Dąbrowska,et al. Human Papillomavirus Infections and the Role Played by Cervical and Cervico-Vaginal Microbiota—Evidence from Next-Generation Sequencing Studies , 2024, Cancers.
[2] G. Campisi,et al. Orogenital Human Papillomavirus Infection and Vaccines: A Survey of High- and Low-Risk Genotypes Not Included in Vaccines , 2023, Vaccines.
[3] L. Forney,et al. The cervical microbiota of Hispanics living in Puerto Rico is nonoptimal regardless of HPV status , 2023, mSystems.
[4] Lokesh Kumar,et al. The Female Reproductive Tract Microbiota: Friends and Foe , 2023, Life.
[5] S. Boussios,et al. HPV and Cervical Cancer: A Review of Epidemiology and Screening Uptake in the UK , 2023, Pathogens.
[6] Xin Li,et al. Roles of vaginal flora in human papillomavirus infection, virus persistence and clearance , 2023, Frontiers in Cellular and Infection Microbiology.
[7] Yuanyue Li,et al. The diversity of vaginal microbiome in women infected with single HPV and multiple genotype HPV infections in China , 2022, Frontiers in Cellular and Infection Microbiology.
[8] P. Gajer,et al. Lactobacillus-dominance and rapid stabilization of vaginal microbiota in combined oral contraceptive pill users examined through a longitudinal cohort study with frequent vaginal sampling over two years , 2022, EBioMedicine.
[9] Eun Chae Moon,et al. Lactobacillus helveticus HY7801 ameliorates bacterial vaginosis by inhibiting biofilm formation and epithelial cell adhesion of Gardnerella vaginalis , 2022, Food Science and Biotechnology.
[10] B. Nedjai,et al. 2022-RA-1195-ESGO Longitudinal study of vaginal microbiome pre- and post-treatment identifies biomarkers for cervical intraepithelial neoplasia 3 (CIN3) , 2022, Translational research/biomarkers.
[11] M. Huynen,et al. In-depth insights into cervicovaginal microbial communities and hrHPV infections using high-resolution microbiome profiling , 2022, npj Biofilms and Microbiomes.
[12] A. Nowakowski,et al. Increased diversity of a cervical microbiome associates with cervical cancer , 2022, Frontiers in Oncology.
[13] J. M. Wessels,et al. The female reproductive tract microbiotas, inflammation, and gynecological conditions , 2022, Frontiers in Reproductive Health.
[14] Shuaicheng Li,et al. Cervicovaginal microbiota significantly changed for HPV-positive women with high-grade squamous intraepithelial lesion , 2022, Frontiers in Cellular and Infection Microbiology.
[15] G. Ingravallo,et al. Association between Cervical Microbiota and HPV: Could This Be the Key to Complete Cervical Cancer Eradication? , 2022, Biology.
[16] Zhen-bo Zhang,et al. Changes in the cervicovaginal microbiota composition of HPV16‐infected patients after clinical treatment , 2022, Cancer medicine.
[17] T. Mizutani,et al. Role of Microbiota in Viral Infections and Pathological Progression , 2022, Viruses.
[18] Bin Zhang,et al. Dysbiosis of Cervical and Vaginal Microbiota Associated With Cervical Intraepithelial Neoplasia , 2022, Frontiers in Cellular and Infection Microbiology.
[19] Dominika Jurášková,et al. Exopolysaccharides Produced by Lactic Acid Bacteria: From Biosynthesis to Health-Promoting Properties , 2022, Foods.
[20] R. Su,et al. The Microbiome as a Key Regulator of Female Genital Tract Barrier Function , 2021, Frontiers in Cellular and Infection Microbiology.
[21] Y. Meng,et al. Characteristics of the Cervicovaginal Microenvironment in Childbearing-Age Women with Different Degrees of Cervical Lesions and HR-HPV Positivity , 2021, Polish journal of microbiology.
[22] M. Huynen,et al. Novel high-resolution targeted sequencing of the cervicovaginal microbiome , 2021, BMC biology.
[23] Yutao Diao,et al. Reproductive tract microbiota of women in childbearing age shifts upon gynecological infections and menstrual cycle , 2021, BMC microbiology.
[24] P. Di Carlo,et al. Socio-Demographic Characteristics and Sexual Behavioral Factors of Patients with Sexually Transmitted Infections Attending a Hospital in Southern Italy , 2021, International journal of environmental research and public health.
[25] Xianyang Zhang,et al. LinDA: linear models for differential abundance analysis of microbiome compositional data , 2021, Genome Biology.
[26] Justin C. Fay,et al. The structure and diversity of strain-level variation in vaginal bacteria , 2021, Microbial genomics.
[27] T. Tsukamoto,et al. Changes to the cervicovaginal microbiota and cervical cytokine profile following surgery for cervical intraepithelial neoplasia , 2021, Scientific Reports.
[28] T. Jin,et al. Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation , 2021, Frontiers in Public Health.
[29] J. Huber,et al. Human papillomavirus persistence or clearance after infection in reproductive age. What is the status? Review of the literature and new data of a vaginal gel containing silicate dioxide, citric acid, and selenite , 2021, Women's health.
[30] M. L. Sallas,et al. Microbiome and Cervical Cancer , 2020, Pathobiology.
[31] L. Than,et al. Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health , 2020, Microbial Cell Factories.
[32] C. Adebamowo,et al. Vaginal microbiota diversity and paucity of Lactobacillus species are associated with persistent hrHPV infection in HIV negative but not in HIV positive women , 2020, Scientific Reports.
[33] V. Gouyer,et al. The Cervicovaginal Mucus Barrier , 2020, International journal of molecular sciences.
[34] Stefan Enroth,et al. Temporal changes in the vaginal microbiota in self-samples and its association with persistent HPV16 infection and CIN2+ , 2020, Virology journal.
[35] T. de Oliveira,et al. Determinants of Vaginal Microbiota Composition , 2020, Frontiers in Cellular and Infection Microbiology.
[36] V. Chiantera,et al. ‘Secondary prevention’ against female HPV infection: literature review of the role of carrageenan , 2020, Expert review of anti-infective therapy.
[37] Charles Nkufi Tango,et al. Taxonomic and Functional Differences in Cervical Microbiome Associated with Cervical Cancer Development , 2020, Scientific Reports.
[38] Wenjing Wang,et al. Human papillomavirus infection and cervical intraepithelial neoplasia progression are associated with increased vaginal microbiome diversity in a Chinese cohort , 2020, BMC Infectious Diseases.
[39] P. Castle,et al. Cervicovaginal microbiome and natural history of HPV in a longitudinal study , 2020, PLoS pathogens.
[40] P. Gajer,et al. VALENCIA: a nearest centroid classification method for vaginal microbial communities based on composition , 2020, Microbiome.
[41] Z. Ilhan,et al. The microbiome and gynaecological cancer development, prevention and therapy , 2020, Nature Reviews Urology.
[42] K. Pal,et al. Contrasting diversity of vaginal lactobacilli among the females of Northeast India , 2019, BMC Microbiology.
[43] Hua Gao,et al. Association between the vaginal microbiome and high-risk human papillomavirus infection in pregnant Chinese women , 2019, BMC Infectious Diseases.
[44] J. H. van de Wijgert,et al. Vaginal dysbiosis and the risk of human papillomavirus and cervical cancer: systematic review and meta-analysis. , 2019, American journal of obstetrics and gynecology.
[45] J. Ravel,et al. The vaginal microbiota and its association with human papillomavirus, Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium infections: a systematic review and meta-analysis. , 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[46] J. Ravel,et al. Cervicovaginal microbiota, women's health, and reproductive outcomes. , 2018, Fertility and sterility.
[47] S. Graham. The human papillomavirus replication cycle, and its links to cancer progression: a comprehensive review. , 2017, Clinical science.
[48] D. Cavalieri,et al. Characterization of cervico-vaginal microbiota in women developing persistent high-risk Human Papillomavirus infection , 2017, Scientific Reports.
[49] A. Firenze,et al. Potential impact of a nonavalent HPV vaccine on HPV related low-and high-grade cervical intraepithelial lesions: A referral hospital-based study in Sicily , 2017, Human vaccines & immunotherapeutics.
[50] P. Gajer,et al. Association of HPV infection and clearance with cervicovaginal immunology and the vaginal microbiota , 2016, Mucosal Immunology.
[51] R. Dunn,et al. Lactobacilli Dominance and Vaginal pH: Why Is the Human Vaginal Microbiome Unique? , 2016, Front. Microbiol..
[52] Mardge H. Cohen,et al. The Cervicovaginal Microbiota and Its Associations With Human Papillomavirus Detection in HIV-Infected and HIV-Uninfected Women. , 2016, The Journal of infectious diseases.
[53] J. Marrazzo,et al. The Vaginal Microbiome: Current Understanding and Future Directions. , 2016, The Journal of infectious diseases.
[54] J. K. Nicholson,et al. Cervical intraepithelial neoplasia disease progression is associated with increased vaginal microbiome diversity , 2015, Scientific Reports.
[55] S. Seo,et al. The association of uterine cervical microbiota with an increased risk for cervical intraepithelial neoplasia in Korea. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[56] Seon-Ho Kim,et al. Effect of Lactobacillus mucosae on In vitro Rumen Fermentation Characteristics of Dried Brewers Grain, Methane Production and Bacterial Diversity , 2014, Asian-Australasian journal of animal sciences.
[57] Jennifer M. Fettweis,et al. Differences in vaginal microbiome in African American women versus women of European ancestry. , 2014, Microbiology.
[58] D. Kang,et al. In vitro evaluation of the mucin‐adhesion ability and probiotic potential of Lactobacillus mucosae LM1 , 2014, Journal of applied microbiology.
[59] J. Klausner,et al. Characterization of culturable vaginal Lactobacillus species among women with and without bacterial vaginosis from the United States and India: a cross-sectional study. , 2014, Journal of medical microbiology.
[60] A. Horii,et al. An Adhesin-Like Protein, Lam29, from Lactobacillus mucosae ME-340 Binds to Histone H3 and Blood Group Antigens in Human Colonic Mucus , 2012, Bioscience, biotechnology, and biochemistry.
[61] P. Gajer,et al. Vaginal microbiome of reproductive-age women , 2010, Proceedings of the National Academy of Sciences.
[62] David J Van Horn,et al. Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities , 2009, Applied and Environmental Microbiology.
[63] D. Brassart,et al. In vitro antibacterial activity of Lactobacillus helveticus strain KS300 against diarrhoeagenic, uropathogenic and vaginosis‐associated bacteria , 2006, Journal of applied microbiology.
[64] Eoin L. Brodie,et al. Greengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible with ARB , 2006, Applied and Environmental Microbiology.
[65] J. A. Plascak,et al. Wang-Landau Monte Carlo simulation of the Blume-Capel model. , 2006, Physical review. E, Statistical, nonlinear, and soft matter physics.
[66] Ben Nichols,et al. Distributed under Creative Commons Cc-by 4.0 Vsearch: a Versatile Open Source Tool for Metagenomics , 2022 .